CVRx (CVRX) Revenue & Revenue Breakdown
CVRx Revenue Highlights
Latest Revenue (Y)
$39.30M
Latest Revenue (Q)
$13.37M
Main Geography (Y)
U.S.
CVRx Revenue by Period
CVRx Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $39.30M | 74.89% |
| 2022-12-31 | $22.47M | 72.36% |
| 2021-12-31 | $13.04M | 115.36% |
| 2020-12-31 | $6.05M | -3.26% |
| 2019-12-31 | $6.26M | - |
CVRx generated $39.30M in revenue during NA 2023, up 74.89% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
CVRx Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $13.37M | 13.26% |
| 2024-06-30 | $11.81M | 9.63% |
| 2024-03-31 | $10.77M | -4.73% |
| 2023-12-31 | $11.30M | 7.55% |
| 2023-09-30 | $10.51M | 10.64% |
| 2023-06-30 | $9.50M | 19.06% |
| 2023-03-31 | $7.98M | 11.19% |
| 2022-12-31 | $7.18M | 16.00% |
| 2022-09-30 | $6.19M | 22.96% |
| 2022-06-30 | $5.03M | 23.43% |
| 2022-03-31 | $4.08M | 11.43% |
| 2021-12-31 | $3.66M | 7.75% |
| 2021-09-30 | $3.40M | 8.71% |
| 2021-06-30 | $3.12M | 9.20% |
| 2021-03-31 | $2.86M | 36.97% |
| 2020-12-31 | $2.09M | 109.43% |
| 2020-09-30 | $997.00K | -20.24% |
| 2020-06-30 | $1.25M | -27.24% |
| 2020-03-31 | $1.72M | - |
CVRx generated $13.37M in revenue during Q3 2024, up 13.26% compared to the previous quarter, and up 140.77% compared to the same period a year ago.
CVRx Revenue Breakdown
CVRx Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Other countries | $494.00K | $971.00K | $639.00K |
| U.S. | $35.11M | $18.02M | $9.15M |
| Germany | $3.69M | $3.48M | $3.25M |
Latest
CVRx's latest annual revenue breakdown by geography, as of Dec 23: U.S. (89.35%), Germany (9.39%), and Other countries (1.26%).
Quarterly Revenue by Country
| Country | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Countries | $266.00K | $332.00K | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | $12.30M | $10.67M | - | - | - | - | - | - | - | - | - | - | - |
| GERMANY | $807.00K | $802.00K | - | - | - | - | - | - | - | - | - | - | - |
| U.S. | - | - | $9.84M | $19.87M | $8.30M | $6.94M | $5.99M | $5.04M | $3.94M | $3.06M | $2.86M | $2.57M | $2.10M |
| Other countries | - | - | $58.00K | $271.00K | $77.00K | $146.00K | $457.00K | $214.00K | $85.00K | $215.00K | $139.00K | $141.00K | $219.00K |
| Germany | - | - | $877.00K | $1.67M | $1.13M | $891.00K | $733.00K | $933.00K | $1.01M | $803.00K | $661.00K | $682.00K | $799.00K |
Latest
CVRx's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (91.98%), GERMANY (6.03%), and Other Countries (1.99%).
CVRx Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.11M |
| AORT | Artivion | $354.00M | $95.78M |
| ANIK | Anika Therapeutics | $166.66M | $38.75M |
| AXGN | AxoGen | $159.01M | $48.64M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $20.16M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| NPCE | NeuroPace | $65.42M | $21.06M |
| CVRX | CVRx | $39.30M | $13.37M |
| OSA | ProSomnus | $27.65M | $7.46M |
| AXDX | Accelerate Diagnostics | $12.06M | $2.98M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |